Literature DB >> 24247126

Widespread dissemination of CTX-M-15 genotype extended-spectrum-β-lactamase-producing enterobacteriaceae among patients presenting to community hospitals in the southeastern United States.

Luke F Chen1, Joshua T Freeman, Brad Nicholson, Anna Keiger, Sarah Lancaster, Maria Joyce, Christopher W Woods, Evelyn Cook, Linda Adcock, Susan Louis, Andrea L Cromer, Daniel J Sexton, Deverick J Anderson.   

Abstract

Extended-spectrum-β-lactamase (ESBL)-producing organisms are increasingly prevalent. We determined the characteristics of 66 consecutive ESBL-producing isolates from six community hospitals in North Carolina and Virginia from 2010 to 2012. Fifty-three (80%) ESBL-producing isolates contained CTX-M enzymes; CTX-M-15 was found in 68% of Escherichia coli and 73% of Klebsiella isolates. Sequence type 131 (ST131) was the commonest type of E. coli, accounting for 48% of CTX-M-15-producing and 66% of CTX-M-14-producing isolates. In conclusion, the CTX-M genotype and ST131 E. coli were common among ESBL isolates from U.S. community hospitals.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24247126      PMCID: PMC3910860          DOI: 10.1128/AAC.01099-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

Review 1.  Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern.

Authors:  Johann D D Pitout; Kevin B Laupland
Journal:  Lancet Infect Dis       Date:  2008-03       Impact factor: 25.071

2.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.

Authors:  Teresa C Horan; Mary Andrus; Margaret A Dudeck
Journal:  Am J Infect Control       Date:  2008-06       Impact factor: 2.918

3.  Emergence of extended-spectrum beta-lactamase-producing Escherichia coli in community hospitals throughout North Carolina: a harbinger of a wider problem in the United States?

Authors:  Joshua T Freeman; Daniel J Sexton; Deverick J Anderson
Journal:  Clin Infect Dis       Date:  2009-07-15       Impact factor: 9.079

4.  Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis.

Authors:  Mitchell J Schwaber; Yehuda Carmeli
Journal:  J Antimicrob Chemother       Date:  2007-09-11       Impact factor: 5.790

Review 5.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

6.  Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge.

Authors:  Jesús Rodríguez-Baño; Maria D Navarro; Luisa Romero; Miguel A Muniain; Marina de Cueto; María J Ríos; José R Hernández; Alvaro Pascual
Journal:  Clin Infect Dis       Date:  2006-10-25       Impact factor: 9.079

7.  Community-associated extended-spectrum β-lactamase-producing Escherichia coli infection in the United States.

Authors:  Yohei Doi; Yoon Soo Park; Jesabel I Rivera; Jennifer M Adams-Haduch; Ameet Hingwe; Emilia M Sordillo; James S Lewis; Wanita J Howard; Laura E Johnson; Bruce Polsky; James H Jorgensen; Sandra S Richter; Kathleen A Shutt; David L Paterson
Journal:  Clin Infect Dis       Date:  2012-11-13       Impact factor: 9.079

8.  Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies.

Authors:  Enrico M Trecarichi; Mario Tumbarello; Teresa Spanu; Morena Caira; Luana Fianchi; Patrizia Chiusolo; Giovanni Fadda; Giuseppe Leone; Roberto Cauda; Livio Pagano
Journal:  J Infect       Date:  2009-03-09       Impact factor: 6.072

9.  Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolates.

Authors:  Johann D D Pitout; Deirdre L Church; Daniel B Gregson; Barbara L Chow; Melissa McCracken; Michael R Mulvey; Kevin B Laupland
Journal:  Antimicrob Agents Chemother       Date:  2007-02-05       Impact factor: 5.191

10.  Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004.

Authors:  James R Johnson; Megan Menard; Brian Johnston; Michael A Kuskowski; Kim Nichol; George G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  2009-04-27       Impact factor: 5.191

View more
  23 in total

1.  Antibiotic-resistant Klebsiella pneumoniae and Escherichia coli high-risk clones and an IncFII(k) mosaic plasmid hosting Tn1 (blaTEM-4) in isolates from 1990 to 2004.

Authors:  Irene Rodríguez; Ângela Novais; Felipe Lira; Aránzazu Valverde; Tânia Curião; José Luis Martínez; Fernando Baquero; Rafael Cantón; Teresa M Coque
Journal:  Antimicrob Agents Chemother       Date:  2015-02-17       Impact factor: 5.191

2.  Characterization of a Novel IncHI2 Plasmid Carrying Tandem Copies of blaCTX-M-2 in a fosA6-Harboring Escherichia coli Sequence Type 410 Strain.

Authors:  Qinglan Guo; Baixing Ding; Thomas Jové; Nicole Stoesser; Vaughn S Cooper; Minggui Wang; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

3.  Diversity of clonal types of Klebsiella pneumoniae causing infections in intensive care neonatal patients in a large urban setting.

Authors:  Livia Helena Justo-da-Silva; Andrea Nunes De-Azeredo; Arnaldo Costa Bueno; Lara Feital Montezzi; Maria Beatriz Gerardin Poirot Leobons; Maria Silvana Alves; Patrícia de Souza Inhaquite; Rosana Rangel Santos; Valéria Brígido Carvalho Girão; Antônio José Ledo Alves da Cunha; Carmem Lucia Pessoa-Silva; Renata Cristina Picão; Cristina Barroso Hofer; Guilherme Santoro-Lopes; Lee Woodland Riley; Beatriz Meurer Moreira
Journal:  Braz J Microbiol       Date:  2019-08-10       Impact factor: 2.476

4.  Statistical detection of geographic clusters of resistant Escherichia coli in a regional network with WHONET and SaTScan.

Authors:  Rachel Park; Thomas F O'Brien; Susan S Huang; Meghan A Baker; Deborah S Yokoe; Martin Kulldorff; Craig Barrett; Jamie Swift; John Stelling
Journal:  Expert Rev Anti Infect Ther       Date:  2016-09-06       Impact factor: 5.091

5.  Genomic Analysis of Multidrug-Resistant Escherichia coli from North Carolina Community Hospitals: Ongoing Circulation of CTX-M-Producing ST131-H30Rx and ST131-H30R1 Strains.

Authors:  Hajime Kanamori; Christian M Parobek; Jonathan J Juliano; James R Johnson; Brian D Johnston; Timothy J Johnson; David J Weber; William A Rutala; Deverick J Anderson
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

6.  Outcomes analysis in patients with extended-spectrum beta-lactamase bacteremia empirically treated with piperacillin/tazobactam versus carbapenems.

Authors:  Reeba John; Peter Colley; Hoa L Nguyen; Mezgebe Berhe
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-03-28

7.  Epidemiology of extended-spectrum β-lactamase-producing Enterobacterales in five US sites participating in the Emerging Infections Program, 2017.

Authors:  Nadezhda Duffy; Maria Karlsson; Hannah E Reses; Davina Campbell; Jonathan Daniels; Richard A Stanton; Sarah J Janelle; Kyle Schutz; Wendy Bamberg; Paulina A Rebolledo; Chris Bower; Rebekah Blakney; Jesse T Jacob; Erin C Phipps; Kristina G Flores; Ghinwa Dumyati; Hannah Kopin; Rebecca Tsay; Marion A Kainer; Daniel Muleta; Benji Byrd-Warner; Julian E Grass; Joseph D Lutgring; J Kamile Rasheed; Christopher A Elkins; Shelley S Magill; Isaac See
Journal:  Infect Control Hosp Epidemiol       Date:  2022-02-14       Impact factor: 6.520

8.  [Prevalence and risk factors for extended-spectrum β-lactamase-producing Escherichia coli causing community-onset urinary tract infections in Colombia].

Authors:  Victor M Blanco; Juan J Maya; Adriana Correa; Marcela Perenguez; Juan S Muñoz; Gabriel Motoa; Christian J Pallares; Fernando Rosso; Lorena Matta; Yamile Celis; Martha Garzon; María V Villegas
Journal:  Enferm Infecc Microbiol Clin       Date:  2016-01-13       Impact factor: 1.731

9.  Increasing Incidence of Extended-Spectrum β-Lactamase-Producing Escherichia coli in Community Hospitals throughout the Southeastern United States.

Authors:  Joshua T Thaden; Vance G Fowler; Daniel J Sexton; Deverick J Anderson
Journal:  Infect Control Hosp Epidemiol       Date:  2015-10-13       Impact factor: 3.254

10.  Extended-spectrum ß-Lactamase-producing Enterobacteriaceae as a Common Cause of Urinary Tract Infections in Sri Lanka.

Authors:  L Gayani Tillekeratne; Dhammika Vidanagama; Rashmi Tippalagama; Rashmi Lewkebandara; Maria Joyce; Bradly P Nicholson; Ajith Nagahawatte; Champica K Bodinayake; Aruna Dharshan De Silva; Christopher W Woods
Journal:  Infect Chemother       Date:  2016-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.